68 Recruiting Studies Using Mycophenolate Mofetil
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Mycophenolate Mofetil
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
๐ University of Chicago โ Chicago, Illinois
Dyskeratosis Congenita
View Study & Checklist โTotal Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
๐ City of Hope Medical Center โ Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist โVorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
๐ University of Colorado โ Aurora, Colorado
Hematologic Diseases
View Study & Checklist โMycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
๐ Northwestern University โ Chicago, Illinois
Astrocytoma
View Study & Checklist โPeritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Primary Myelofibrosis
View Study & Checklist โBusulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
๐ M D Anderson Cancer Center โ Houston, Texas
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist โHLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
๐ City of Hope National Medical Center โ Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist โRuxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Aplastic Anemia
View Study & Checklist โA Blood Stem Cell Transplant for Sickle Cell Disease
๐ City of Hope Medical Center โ Duarte, California
Sickle Cell Disease
View Study & Checklist โTrial Evaluating MGTA-456 in Patients With High-Risk Malignancy
๐ Masonic Cancer Center at University of Minnesota โ Minneapolis, Minnesota
Acute Myeloid Leukemia
View Study & Checklist โChemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
๐ Roswell Park Cancer Institute โ Buffalo, New York
Acute Myeloid Leukemia in Remission
View Study & Checklist โTandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
๐ Washington University โ St Louis, Missouri
Lymphoma, Non-Hodgkin
View Study & Checklist โCombination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
๐ City of Hope Medical Center โ Duarte, California
Secondary Myelofibrosis
View Study & Checklist โHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
๐ Mayo Clinic Arizona โ Phoenix, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist โCytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
๐ Washington University School of Medicine โ St Louis, Missouri
Acute Myeloid Leukemia
View Study & Checklist โOptimizing PTCy Dose and Timing
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Graft Versus Host Disease
View Study & Checklist โSorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
๐ M D Anderson Cancer Center โ Houston, Texas
Recurrent Acute Myeloid Leukemia
View Study & Checklist โAllogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
GATA2
View Study & Checklist โDe-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
๐ Froedtert Hospital & the Medical College of Wisconsin โ Milwaukee, Wisconsin
Graft-versus-host Disease
View Study & Checklist โReduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
๐ Stanford University โ Stanford, California
Allogeneic Hematopoietic Cell Transplantation (HCT)
View Study & Checklist โMismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
๐ Children's Hospital of Alabama โ Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist โMycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
๐ University of Michigan Rogel Cancer Center โ Ann Arbor, Michigan
Recurrent Glioblastoma
View Study & Checklist โAutomated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
๐ Stanford University โ Palo Alto, California
Acute Myeloid Leukemia
View Study & Checklist โStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Core Binding Factor Alpha Subunits
View Study & Checklist โMycophenolate After Stem Cell Transplant for Systemic Sclerosis
๐ The Ottawa Hospital โ Ottawa, Ontario
Systemic Sclerosis (SSc)
View Study & Checklist โAxatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
๐ Mayo Clinic in Arizona โ Scottsdale, Arizona
Hematopoietic and Lymphatic System Neoplasm
View Study & Checklist โA Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
๐ Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) โ Basking Ridge, New Jersey
Hematologic Malignancies
View Study & Checklist โAllo HSCT Using RIC and PTCy for Hematological Diseases
๐ Masonic Cancer Center at University of Minnesota โ Minneapolis, Minnesota
Acute Myelogenous Leukemia
View Study & Checklist โEmapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
๐ City of Hope Medical Center โ Duarte, California
Acute Myeloid Leukemia
View Study & Checklist โStudy of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
๐ University of Illinois at Chicago โ Chicago, Illinois
Sickle Cell Disease
View Study & Checklist โFludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
๐ Lombardi Comprehensive Cancer Center at Georgetown University Medical Center โ Washington D.C., District of Columbia
Allogeneic Stem Cell Transplant Recipient
View Study & Checklist โReduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Primary Myelofibrosis
View Study & Checklist โThe Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
๐ University of California, San Francisco โ San Francisco, California
Lupus Nephritis
View Study & Checklist โABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
๐ University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center โ Cleveland, Ohio
Acute Myelogenous Leukemia
View Study & Checklist โA Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Immunodeficiency
View Study & Checklist โA Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
๐ The University of Texas M. D. Anderson Cancer Center โ Houston, Texas
AML
View Study & Checklist โBelatacept in De Novo Heart Transplantation
๐ NYU Langone Health โ New York, New York
Heart Transplantation
View Study & Checklist โAllo HSCT for High Risk Hemoglobinopathies
๐ Masonic Cancer Center โ Minneapolis, Minnesota
Graft Failure
View Study & Checklist โReduced Immunosuppression in Older Renal Transplant Recipients With Trugrafยฎ/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
๐ Mayo Clinic โ Phoenix, Arizona
Kidney Transplantation
View Study & Checklist โCord Blood Transplantation in Children and Young Adults With Blood Cancer
๐ Memorial Sloan Kettering Cancer Center (All Protocol Activities) โ New York, New York
Acute Myelogenous Leukemia
View Study & Checklist โPhase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Hematologic Malignancies
View Study & Checklist โMT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
๐ Masonic Cancer Center at University of Minnesota โ Minneapolis, Minnesota
AML
View Study & Checklist โMT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
๐ University of Minnesota Masonic Cancer Center โ Minneapolis, Minnesota
Severe Aplastic Anemia
View Study & Checklist โTotal Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Non-Malignant Neoplasm
View Study & Checklist โRuxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
๐ OHSU Knight Cancer Institute โ Portland, Oregon
Acute Myeloid Leukemia
View Study & Checklist โCord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
๐ Memorial Sloan Kettering Cancer Center โ New York, New York
AML
View Study & Checklist โAdvancing Transplantation Outcomes in Children
๐ University of Alabama at Birmingham (Site # 71038) โ Birmingham, Alabama
Kidney Transplant
View Study & Checklist โMycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
๐ Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) โ Montreal, Quebec
Systemic Sclerosis With Lung Involvement
View Study & Checklist โA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
๐ Loma Linda University health โ Loma Linda, California
Lupus Nephritis
View Study & Checklist โOptimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
๐ The University of Texas M. D. Anderson Cancer Center โ Houston, Texas
Hematologic Malignancies
View Study & Checklist โDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Acute Leukemia
View Study & Checklist โCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Acute Leukemia of Ambiguous Lineage
View Study & Checklist โA Study of Immune Suppression Treatment for People With Sickle Cell Disease or ฮฒ-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
๐ Memorial Sloan Kettering at Basking Ridge (Consent only) โ Basking Ridge, New Jersey
Sickle Cell Disease
View Study & Checklist โAllogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
GATA2
View Study & Checklist โBelatacept in Heart Transplantation
๐ Cedars Sinai Heart Institute/ Cedars Sinai Medical (Site # 71146) โ Los Angeles, California
Heart Transplant
View Study & Checklist โA Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
๐ Stanford Cancer Center โ Palo Alto, California
Graft-versus-host Disease (GVHD)
View Study & Checklist โEarly Use of Long-acting Tacrolimus in Lung Transplant Recipients
๐ Vanderbilt University Medical Center โ Nashville, Tennessee
Lung Transplant; Complications
View Study & Checklist โA Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
๐ Local Institution - 0042 โ Birmingham, Alabama
Renal Allograft Recipients
View Study & Checklist โAllogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist โCLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Recurrent Acute Myeloid Leukemia
View Study & Checklist โA Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
๐ Brigham & Women's Hospital- Site Number : 8400049 โ Boston, Massachusetts
Kidney Transplant Rejection
View Study & Checklist โDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Hematologic Neoplasms
View Study & Checklist โBendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
๐ M D Anderson Cancer Center โ Houston, Texas
Hematopoietic and Lymphoid System Neoplasm
View Study & Checklist โ211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Acute Lymphoblastic Leukemia
View Study & Checklist โRegenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
๐ Johns Hopkins University โ Baltimore, Maryland
Primary Immune Deficiency Disorder
View Study & Checklist โOptimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
๐ University of Nebraska Medical Center โ Omaha, Nebraska
Hematological Malignancies
View Study & Checklist โ211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
๐ Fred Hutch/University of Washington Cancer Consortium โ Seattle, Washington
Acute Lymphoblastic Leukemia in Remission
View Study & Checklist โPhase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
๐ National Institutes of Health Clinical Center โ Bethesda, Maryland
Hematologic Neoplasms
View Study & Checklist โ